Skip to main content
PMC home page
Gut logoLink to Gut
. 1997 Apr;40(4):440–442. doi: 10.1136/gut.40.4.440

Autoimmune cholangitis.

J Heathcote 1
PMCID: PMC1027114  PMID: 9176067

Full text

PDF
440

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Ari Z., Dhillon A. P., Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology. 1993 Jul;18(1):10–15. [PubMed] [Google Scholar]
  2. Bernstein R. M., Neuberger J. M., Bunn C. C., Callender M. E., Hughes G. R., Williams R. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol. 1984 Mar;55(3):553–560. [PMC free article] [PubMed] [Google Scholar]
  3. Brunner G., Klinge O. Ein der chronisch-destruierenden nicht-eitrigen Cholangitis ähnliches Krankheitsbild mit antinukleären Antikörpern (Immuncholangitis). Dtsch Med Wochenschr. 1987 Sep 18;112(38):1454–1458. doi: 10.1055/s-2008-1068269. [DOI] [PubMed] [Google Scholar]
  4. Combes B., Carithers R. L., Jr, Maddrey W. C., Lin D., McDonald M. F., Wheeler D. E., Eigenbrodt E. H., Muñoz S. J., Rubin R., Garcia-Tsao G. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 1995 Sep;22(3):759–766. [PubMed] [Google Scholar]
  5. Fussey S. P., Ali S. T., Guest J. R., James O. F., Bassendine M. F., Yeaman S. J. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A. 1990 May;87(10):3987–3991. doi: 10.1073/pnas.87.10.3987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Geubel A. P., Baggenstoss A. H., Summerskill W. H. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology. 1976 Sep;71(3):444–449. [PubMed] [Google Scholar]
  7. Goodman Z. D., McNally P. R., Davis D. R., Ishak K. G. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci. 1995 Jun;40(6):1232–1242. doi: 10.1007/BF02065530. [DOI] [PubMed] [Google Scholar]
  8. Gordon S. C., Quattrociocchi-Longe T. M., Khan B. A., Kodali V. P., Chen J., Silverman A. L., Kiechle F. L. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology. 1995 Jun;108(6):1802–1809. doi: 10.1016/0016-5085(95)90143-4. [DOI] [PubMed] [Google Scholar]
  9. Heathcote E. J., Cauch-Dudek K., Walker V., Bailey R. J., Blendis L. M., Ghent C. N., Michieletti P., Minuk G. Y., Pappas S. C., Scully L. J. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 1994 May;19(5):1149–1156. [PubMed] [Google Scholar]
  10. Kitami N., Komada T., Ishii H., Shimizu H., Adachi H., Yamaguchi Y., Kitamura T., Oide H., Miyazaki A., Ishikawa M. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med. 1995 Jun;34(6):496–501. doi: 10.2169/internalmedicine.34.496. [DOI] [PubMed] [Google Scholar]
  11. Klatskin G., Kantor F. S. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med. 1972 Oct;77(4):533–541. doi: 10.7326/0003-4819-77-4-533. [DOI] [PubMed] [Google Scholar]
  12. Lacerda M. A., Ludwig J., Dickson E. R., Jorgensen R. A., Lindor K. D. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol. 1995 Feb;90(2):247–249. [PubMed] [Google Scholar]
  13. Lindor K. D., Dickson E. R., Baldus W. P., Jorgensen R. A., Ludwig J., Murtaugh P. A., Harrison J. M., Wiesner R. H., Anderson M. L., Lange S. M. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology. 1994 May;106(5):1284–1290. doi: 10.1016/0016-5085(94)90021-3. [DOI] [PubMed] [Google Scholar]
  14. Michieletti P., Wanless I. R., Katz A., Scheuer P. J., Yeaman S. J., Bassendine M. F., Palmer J. M., Heathcote E. J. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut. 1994 Feb;35(2):260–265. doi: 10.1136/gut.35.2.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mutimer D. J., Fussey S. P., Yeaman S. J., Kelly P. J., James O. F., Bassendine M. F. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology. 1989 Oct;10(4):403–407. doi: 10.1002/hep.1840100402. [DOI] [PubMed] [Google Scholar]
  16. Poupon R. E., Poupon R., Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. N Engl J Med. 1994 May 12;330(19):1342–1347. doi: 10.1056/NEJM199405123301903. [DOI] [PubMed] [Google Scholar]
  17. Sherlock S., Scheuer P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973 Sep 27;289(13):674–678. doi: 10.1056/NEJM197309272891306. [DOI] [PubMed] [Google Scholar]
  18. Shimoda S., Nakamura M., Ishibashi H., Hayashida K., Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med. 1995 May 1;181(5):1835–1845. doi: 10.1084/jem.181.5.1835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Taylor S. L., Dean P. J., Riely C. A. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol. 1994 Jan;18(1):91–99. [PubMed] [Google Scholar]
  20. Tsuneyama K., Van De Water J., Van Thiel D., Coppel R., Ruebner B., Nakanuma Y., Dickson E. R., Gershwin M. E. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology. 1995 Nov;22(5):1440–1446. [PubMed] [Google Scholar]
  21. Tsuneyama K., Van de Water J., Leung P. S., Cha S., Nakanuma Y., Kaplan M., De Lellis R., Coppel R., Ansari A., Gershwin M. E. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology. 1995 Apr;21(4):1031–1037. [PubMed] [Google Scholar]
  22. Van de Water J., Turchany J., Leung P. S., Lake J., Munoz S., Surh C. D., Coppel R., Ansari A., Nakanuma Y., Gershwin M. E. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest. 1993 Jun;91(6):2653–2664. doi: 10.1172/JCI116504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]
  24. Zauli D., Schrumpf E., Crespi C., Cassani F., Fausa O., Aadland E. An autoantibody profile in primary sclerosing cholangitis. J Hepatol. 1987 Aug;5(1):14–18. doi: 10.1016/s0168-8278(87)80055-7. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES